tradingkey.logo

Moderate US flu season supportive for NZ's Fisher & Paykel, Jefferies says

ReutersFeb 9, 2026 6:37 PM

Jefferies says, with current U.S. flu season largely progressing as expected, it helps Fisher & Paykel Healthcare FPH.NZ meet its FY26 guidance

New Zealand-based medical equipment maker manufactures products for use in acute and chronic respiratory care and has operations in the U.S.

Jefferies notes the CDC continues to expect a moderate 2025-26 season, but flags elevated flu incidence amongst children

Brokerage also notes co's estimate that less than 5% of its hospital business is attributable to seasonal effects

Stock up 4.1% so far this year, as of last close

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI